Elena N.Parovichnikova
Quick facts
Phase 3 pipeline
- R-BL-M-04 · unknown
R-BL-M-04 is a small molecule drug that targets the molecular target. - R-BL-M-04 + auto-SCT · Oncology
R-BL-M-04 is a conditioning regimen for auto-SCT, which involves the use of a specific chemotherapy regimen to prepare the patient's body for a stem cell transplant.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: